Medicare Enrolled

Dr. Karan Madan, MD

Pain Medicine · Sugar Land, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
15591 CREEK BEND DR, Sugar Land, TX 77478
7139737246
In practice since 2006 (19 years)
NPI: 1568410397 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Madan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Madan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Madan

Dr. Karan Madan is a pain medicine specialist in Sugar Land, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Madan performed 6,876 Medicare services across 2,206 unique beneficiaries.

Between the years covered by Open Payments, Dr. Madan received a total of $22,453 from 69 pharmaceutical and/or device companies across 427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Madan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 8% volume in TX $22,453 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,876
Medicare services
Top 8% in TX for pain medicine
2,206
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~362 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,281 $97 $333
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
1,040 $0 $10
Injection, methylprednisolone acetate, 40 mg 910 $6 $50
Midazolam injection, per 1 mg
Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments.
789 $0 $10
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
453 $0 $5
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
428 $61 $343
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
231 $11 $37
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
230 $67 $236
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
178 $209 $761
Additional sacral spine nerve root injection with imaging
An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging.
137 $87 $299
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
120 $1 $12
Contrast dye for imaging, lower concentration 110 $0 $10
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
96 $46 $153
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
80 $61 $217
Fluoroscopic guidance for needle placement
Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure.
80 $78 $310
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
79 $127 $434
Spinal drug pump reprogramming and refill
A physician electronically adjusts the settings of a spinal drug infusion pump and refills its medication reservoir.
70 $72 $247
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
66 $146 $561
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
62 $498 $2,108
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
61 $273 $1,177
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
50 $197 $852
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
49 $102 $445
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
43 $87 $291
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
42 $43 $147
Spinal injection with imaging guidance
A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location.
36 $204 $703
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
26 $42 $162
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
26 $102 $402
Injection of anesthetic agent and/or steroid into other nerve or branch 25 $56 $240
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint.
25 $252 $946
Facet joint nerve destruction, single joint
This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint.
21 $431 $1,683
Ultrasound of arm or leg veins
An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers.
18 $146 $503
Trigger point injection, 1-2 muscles
A procedure involving the injection of medication into one or two specific muscles to treat trigger points.
14 $21 $141
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$22,453
Total received (2018-2024)
Avg $3,208/year across 7 years
Top 11% in TX for pain medicine
69
Companies
427
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$11,837 (52.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,616 (47.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,003
2023
$681
2022
$1,312
2021
$911
2020
$1,193
2019
$1,904
2018
$15,449

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
BOSTON SCIENTIFIC CORPORATION
$11,747
Vertiflex, Inc.
$1,515
Collegium Pharmaceutical, Inc.
$1,172
Abbott Laboratories
$1,148
Nevro Corp.
$875
Horizon Therapeutics plc
$768
Boston Scientific Corporation
$741
Medtronic USA, Inc.
$463
Horizon Pharma plc
$342
ARBOR PHARMACEUTICALS, INC.
$290
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$236
Medtronic, Inc.
$224
SI-BONE, Inc.
$207
Biogen, Inc.
$167
Scilex Pharmaceuticals Inc.
$150
Kaleo, Inc.
$139
ABBVIE INC.
$127
BioDelivery Sciences International, Inc.
$105
Daiichi Sankyo Inc.
$105
Saluda Medical Americas, Inc.
$98
Arbor Pharmaceuticals, Inc.
$88
Stimwave Technologies Incorporated
$86
SCILEX PHARMACEUTICALS INC.
$84
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$84
Vertical Pharmaceuticals, LLC
$81
Forte Bio-Pharma LLC
$71
Shionogi Inc
$69
ASSERTIO THERAPEUTICS, Inc.
$66
Innovation Technologies Inc
$54
Assertio Therapeutics, Inc.
$52
Zyla Life Sciences, Inc.
$51
Nuvectra Corporation
$51
Pacira Pharmaceuticals Incorporated
$49
Azurity Pharmaceuticals, Inc.
$48
RedHill Biopharma Inc.
$48
Medtronic Vascular, Inc.
$46
Pernix Therapeutics Holdings, Inc.
$44
DePuy Synthes Sales Inc.
$41
Hikma Pharmaceuticals USA
$40
Egalet US Inc
$37
Biohaven Pharmaceuticals, Inc.
$35
Avanos Medical
$34
INSYS Therapeutics Inc
$34
Nalu Medical, Inc.
$33
Biohaven Pharmaceutical Holding Company Ltd.
$33
PFIZER INC.
$32
Novartis Pharmaceuticals Corporation
$30
Promius Pharma LLC
$28
FORTE BIO-PHARMA LLC
$25
Purdue Pharma L.P.
$25
Medline Industries, Inc.
$25
Merz North America, Inc.
$24
Almatica Pharma LLC
$23
Zyla Life Sciences
$22
SANOFI-AVENTIS U.S. LLC
$22
Allergan Inc.
$21
Kowa Pharmaceuticals America, Inc.
$21
Vanda Pharmaceuticals Inc.
$20
SPR Therapeutics, Inc
$20
PAINTEQ LLC
$19
IBSA Pharma Inc.
$16
Orthogenrx Inc.
$16
Teva Pharmaceuticals USA, Inc.
$15
Venclose Inc.
$15
BIOTRONIK NRO, Inc.
$14
Avanir Pharmaceuticals, Inc.
$14
Flowonix Medical Incorporated
$12
West Therapeutics Development, LLC
$11
Amniox Medical, Inc.
$8
Top 3 companies account for 64.3% of total payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · AJOVY · Algovita · BELBUCA · BOTOX · BOTOX - NEUROLOGY · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · COOLIEF* COOLED RADIOFREQUENCY · Cambia · ClosureFast · DUEXIS · ETERNA · Evoke SCS · Evzio · Exparel · GENERAL PAIN MANAGEMENT · GRALISE · GenVisc 850 · Gralise · HETLIOZ · HORIZANT · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · IRRISEPT · Kloxxado · LORZONE · LYRICA · Lazanda · Licart · MONOVISC · Morphabond ER · Movantik · NALOCET · NEOX · NO_PRODUCT · NUEDEXTA · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · ORTHOVISC · Omnia · PAINTEQ · PENNSAID · PRECISION · PROCLAIM · PROLATE · Proclaim Family of SCS IPGs · Prometra II · Prospera · RAYOS · RELISTOR · RELISTOR ORAL · RESTORE · SCS IPGs · SEGLENTIS · SPECTRA WAVEWRITER · SPINRAZA · SPRINT PNS System · SPRIX · SUBSYS · SYMPROIC · SYNCHROMED · SYNVISC-ONE · Senza · Senza Spinal Cord Stimulation System · Sterile Packing Gauze by FABCO · Superion ISS · Superion Indirect Decompression System · Symproic · TRIVISC SODIUM HYALURONATE · VANTA ADAPTIVESTIM · VENASEAL · Vanta · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XEOMIN · XTAMPZA · Xtampza ER · ZEMBRACE SYMTOUCH · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zipsor · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (53%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $327 per 100 Medicare services performed
Looking for a pain medicine specialist in Sugar Land?
Compare pain medicines in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
65
Per 100K population
7.6
County median income
$113,409
Nearest hospital
ST LUKE'S SUGAR LAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Madan is a clinical cardiology specialist, with above-average Medicare volume (top 8% in TX), with speaking/promotional industry engagement in the top 11% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Madan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Madan performed 1,281 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Madan receive payments from pharmaceutical companies?
Yes. Dr. Madan received a total of $22,453 from 69 companies across 427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Madan's costs compare to other pain medicines in Sugar Land?
Dr. Madan's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Madan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →